Rotavirus and pneumococcal vaccine in EPI schedule, American Region, 2009.

Mar 17, 2012

10 likes | 223 Views

Rotavirus and pneumococcal vaccine in EPI schedule, American Region, 2009. Canada. Rotavirus. United States. Honduras. Pneumococcal. Barbados. México. Venezuela. Costa Rica. Both . El Salvador. Guyana. Pneumococcal high risk groups Argentina, Brazil, Ecuador, and, Panama.

Share Presentation

Embed Code

Link

cayman island
venezuela costa rica
rotavirus
barbados m
high risk groups
cayman island nicaragua panam

rehan

Download Presentation

Rotavirus and pneumococcal vaccine in EPI schedule, American Region, 2009.

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

Rotavirus and pneumococcal vaccine in EPI schedule, American Region, 2009. Canada Rotavirus United States Honduras Pneumococcal Barbados México Venezuela Costa Rica Both El Salvador Guyana Pneumococcal high risk groups Argentina, Brazil, Ecuador, and, Panama. Territories with Pneumococcal in EPI schedule: Bermuda and Cayman Island. Territories with Rotavirus in EPI schedule: Cayman Island Nicaragua Panamá Colombia Brazil Ecuador Bolivia Peru Uruguay

Pneumococcal Conjugate Vaccine for Immunocompromised Patients

Risk and Immune Response to Polysaccharides. Age (i.e., elderly)Other immunocompromised groups. Protective Response Documented to Decline with Age. Production of high affinity antibodies aLong-lasting memory response to immunization bDTH to antigens seen in earlier life ca Goidl, et al. J. Exp. Med. 144, 1037 (1976)b McElhaney, et al. J. Gerentol. Med. Sci. 47, MS (1992)c Roberts-Thomson, et al., Lancet ii, 368 (1974).

1.15k views • 36 slides

PNEUMOCOCCAL VACCINE

HISTORY. PNEUMOCOCCUS - First identified in 1881 by PasteurMore than 80 serotypes of pneumococci described by 1940Central role of Ab in host defense against extracellular organisms was first described for PneumococcusFirst recognition that Ab directed to capsular polysaccharide of a bacteria coul

1.14k views • 38 slides

Pneumococcal Vaccine AVI version 0.1

Pneumococcal Vaccine AVI version 0.1. Stefano Malvolti Director Strategic Vaccine Supply AVI Project August 25 th, 2009. Objectives of today. Provide overview on AVI strategic forecasting process and responsibility for Pneumococcal vaccine

450 views • 22 slides

Accelerating pneumococcal and rotavirus vaccine introduction

Introduction. Accelerating pneumococcal and rotavirus vaccine introduction is central to the GAVI mission and critical to assist countries to improve progress towards the Millennium Development GoalsThe Alliance proposes an approach with a role for each partner, additional support from civil socie

375 views • 17 slides

Training for rotavirus vaccine introduction

Training for rotavirus vaccine introduction. Module 2 Rotavirus vaccine attributes and storage conditions. Learning objectives. At the end of the module, the participant will be able to: Describe the main attributes of rotavirus vaccine Describe storage conditions of rotavirus vaccine

437 views • 11 slides

Training for rotavirus vaccine introduction

Learning objectives. At the end of the module, the participant will be able to:Describe how to communicate with caretakersAdvise caretakers on rotavirus disease and prevention methods particularly on the need for timely vaccinationAlert caretakers of potential side effects and how to respond to t

326 views • 17 slides

Pneumococcal Polysaccharide Vaccine (PPSV23) Recommendations

Pneumococcal Polysaccharide Vaccine (PPSV23) Recommendations. Unvaccinated adults 65 years of age and older Adults 19 through 64 years of age with chronic conditions cardiovascular disease pulmonary disease (including asthma) diabetes mellitus a lcoholism chronic liver disease

427 views • 12 slides

Countries Using Pneumococcal Conjugate Vaccine in National Immunization Schedule and Planned Introductions

183 views • 1 slides

Pneumococcal Vaccine in Children

Pneumococcal Vaccine in Children. Pneumococcal Vaccine in Children Dr. Kwan Yat-wah Department of Paediatrics and Adolescent Medicine Princess Margaret Hospital. Streptococcus pneumoniae ( Pneumococcus). Gram Positive, -hemolytic encapsulated diplococcus

1.02k views • 74 slides

Rotavirus Vaccine

Updates & WHO Position Vikash R. Keshri Dept. of Community Medicine. Rotavirus Vaccine. Introduction Problem statement Epidemiology Rotavirus Vaccines Evidences for WHO Position WHO position Recommendations in India. Introduction:.

929 views • 40 slides

Rotavirus vaccine impact

Rotavirus vaccine impact. Introduction . Rotavirus vaccines lead to significant reductions in severe and fatal diarrhea in both vaccinated and unvaccinated children. Rotavirus vaccines are saving lives and improving health in countries where children have access to them.

279 views • 10 slides

Training for rotavirus vaccine introduction

Training for rotavirus vaccine introduction. Module 3 Rotavirus vaccine eligibility. Learning objectives. At the end of the module, the participant will be able to: Describe the recommended immunization schedule for rotavirus vaccine

330 views • 10 slides

Module 6 Rotavirus vaccine AEFI monitoring

Training for rotavirus vaccine introduction. Module 6 Rotavirus vaccine AEFI monitoring. Learning objectives. At the end of the module, the participants will be able to: Identify adverse events following immunization (AEFIs), including intussusception (IS) Explain how to report AEFIs

325 views • 10 slides

Vaccine Preventable Diseases: Pneumococcal Vaccine

Vaccine Preventable Diseases: Pneumococcal Vaccine An Opening Wedge for New Vaccine Introduction and Development. Presented by: Christopher W. Woods Slides Prepared by Orin Levine Executive Director, International Vaccine Access Center Professor, International Health

1.06k views • 49 slides

EPI Plan & Schedule

EPI Plan & Schedule. Dennis Coyne April 18, 2003. Recommended Plan? Depends on Review Committee Recommendations, Action Items & Questions. Unless the outcome of this review is a decision on HEPI or MEPI … Commit to EPI Submit CCB package:

202 views • 6 slides

Training for rotavirus vaccine introduction

Training for rotavirus vaccine introduction. Module 5 Recording and monitoring uptake of rotavirus vaccine. Learning objectives. At the end of the module, the participant will be able to: Record vaccination on the child’s immunization card

255 views • 14 slides

Training for rotavirus vaccine introduction

Training for rotavirus vaccine introduction. Module 4 Rotavirus vaccine administration. Learning objectives. At the end of the module, the participant will be able to: Identify the necessary steps to assure good vaccine quality Describe the method to administer the vaccine

391 views • 21 slides

HPV Vaccine Schedule

Ideally, vaccines for HPV should be administered before a child reaches their teen years. Some people are surprised by the recommended age for HPV vaccination, but itu2019s most effective when given at an early age. Teens and adults can also receive the vaccine, but they need more doses and it may not be as effective when administered later in life. Visit for more info. https://hpvhub.com/hpv-vaccine-schedule/

59 views • 5 slides

Training for rotavirus vaccine introduction

232 views • 21 slides

Pneumococcal vaccine

Pneumococcal vaccine. Polyvalent Untoward reaction in older children and adult Responsiveness is unpredictable in children younger than 2

388 views • 27 slides

Training for rotavirus vaccine introduction

Training for rotavirus vaccine introduction. Module 2 Rotavirus vaccine attributes and storage conditions. Learning objectives. At the end of the module, the participant will be able to: Describe the main attributes of RotaTeq vaccine Describe storage conditions of RotaTeq vaccine Duration

177 views • 14 slides

Training for rotavirus vaccine introduction

Training for rotavirus vaccine introduction. Module 7 Communicating about rotavirus vaccine with caretakers. Learning objectives. At the end of the module, the participant will be able to: Describe how to communicate with caretakers

175 views • 16 slides

More Related

Rotavirus and pneumococcal vaccine in EPI schedule, American Region, 2009.

Rotavirus and pneumococcal vaccine in EPI schedule, American Region, 2009.

Presentation Transcript

Pneumococcal Conjugate Vaccine for Immunocompromised Patients

PNEUMOCOCCAL VACCINE

Pneumococcal Vaccine AVI version 0.1

Accelerating pneumococcal and rotavirus vaccine introduction

Training for rotavirus vaccine introduction

Training for rotavirus vaccine introduction

Pneumococcal Polysaccharide Vaccine (PPSV23) Recommendations

Countries Using Pneumococcal Conjugate Vaccine in National Immunization Schedule and Planned Introductions

Pneumococcal Vaccine in Children

Rotavirus Vaccine

Rotavirus vaccine impact

Training for rotavirus vaccine introduction

Module 6 Rotavirus vaccine AEFI monitoring

Vaccine Preventable Diseases: Pneumococcal Vaccine

EPI Plan &amp; Schedule

Training for rotavirus vaccine introduction

Training for rotavirus vaccine introduction

HPV Vaccine Schedule

Training for rotavirus vaccine introduction

Pneumococcal vaccine

Training for rotavirus vaccine introduction

Training for rotavirus vaccine introduction

EPI Plan & Schedule